TITLE

CSCI/CITAC Young Investigators Forum Abstracts

PUB. DATE
August 2010
SOURCE
Clinical & Investigative Medicine;Aug2010, Vol. 33 Issue 4, preceding p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts on medical topics which include the role of natural killer cells in the induction of chimerism, the development of a stem cell delivery system for treating retinal degenerative diseases, and the impact of chemotherapy on oncolytic virus-induced anti-leukemia immunity.
ACCESSION #
58602611

 

Related Articles

  • Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Ribeiro, Andreia; Laranjeira, Paula; Mendes, Sandrine; Velada, Isabel; Leite, Cristiana; Andrade, Pedro; Santos, Francisco; Henriques, Ana; Grãos, Mário; Cardoso, Carla; Martinho, António; Pais, MLuísa; Da Silva, Cláudia Lobato; Cabral, Joaquim; Trindade, Hélder; Paiva, Artur // Stem Cell Research & Therapy;2013, Vol. 4 Issue 5, p1 

    Introduction The ability to self-renew, be easily expanded in vitro and differentiate into different mesenchymal tissues, render mesenchymal stem cells (MSCs) an attractive therapeutic method for degenerative diseases. The subsequent discovery of their immunosuppressive ability encouraged...

  • High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies. Kwong, Y.-L. // Bone Marrow Transplantation;Dec2009, Vol. 44 Issue 11, p709 

    Natural killer (NK)-cell lymphomas are aggressive. Patients with early (stage I/II) diseases respond favorably to radiotherapy and chemotherapy. Patients with relapses and advanced (stage III/IV) diseases have poor outcome. To improve treatment results, high-dose chemotherapy with hematopoietic...

  • Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation. Nawa, Y; Takenaka, K; Shinagawa, K; Deguchi, S; Matsumura, N; Koyama, S; Hiramatsu, Y; Omoto, E; Yoshino, T; Harada, M // Bone Marrow Transplantation;6/15/99, Vol. 23 Issue 12, p1321 

    CD56+ angiocentric lymphoma has currently been recognized as a distinct clinical entity which is the prototype of the putative NK cell lymphomas. A 16-year-old Japanese girl with advanced CD56+ angiocentric lymphoma received high-dose chemotherapy supported with syngeneic peripheral blood stem...

  • Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. A-Reum Han; Hye Lee; Byeong-Bae Park; In Hwang; Sarah Park; Sang Lee; Kihyun Kim; Ho Lim; Young Ko; Sun Kim; Won Kim // Annals of Hematology;Jul2007, Vol. 86 Issue 7, p493 

    The clinical features and prognostic factor of lymphoma-associated hemophagocytic syndrome (LAHS), diagnosed according to World Health Organization classification, were investigated by reviewing the clinical records of 29 patients between September 1994 and September 2006. Compared with patients...

  • Stem cells: Hidden talents. Bussell, Katrin // Nature Reviews Molecular Cell Biology;Aug2003, Vol. 4 Issue 8, p596 

    Discusses the effectiveness of Wnt signalling in treating neuromuscular degenerative disease. Increase in the proportion of cells expressing CD45 and stem cell antigen-1 in regenerating tissues compared to uninjured cells; Proliferation of myoblasts; Relevance of Wnt signalling in in vivo.

  • Stem cells and degenerative diseases. de Carvalho, Antonio Carlos // BMC Proceedings;10/1/2014, p1 

    An abstract of the article "Stem cells and degenerative diseases" by Antonio Carlos de Carvalho is presented.

  • The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses. Frei III, E; Richardson, P; Avigan, D; Bunnell, C; Wheeler, C; Elias, A // Bone Marrow Transplantation;11/1/99, Vol. 24 Issue 9, p939 

    The interval between courses of chemotherapy have classically been kept to a minimum in order to maximize dose intensity. Certain clinical observations suggest that longer intervals, particularly in the high-dose setting, may be more effective. This is based in part on the evidence that...

  • Generation of dopaminergic neurons from embryonic stem cells. Sasai, Yoshiki // Journal of Neurology;Sep2002 Supplement 2, Vol. 249, pii41 

    Neuronal transplantation is considered to be a promising therapeutic approach to neurodegenerative diseases. In addition to fetal tissues and neural stem cells, embryonic stem cells are good candidates for the creation of neurons. We have recently identified a stromal cell-derived inducing...

  • Stem cell see-saw. Margottini, Laura // New Scientist;4/6/2013, Vol. 217 Issue 2911, p31 

    The article reports that Italy's minister of health, Renato Balduzzi, has signed a legislative bill authorizing The Stamina Foundation to continue its administration of a controversial stem cell therapy on people with a range of degenerative diseases.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics